Successful pembrolizumab treatment of microsatellite instability‐high intrahepatic cholangiocarcinoma: A case report

Yuki Ikeda,Michihiro Ono,Ginji Ohmori,Saki Ameda,Michiko Yamada,Tomoyuki Abe,Shigeyuki Fujii,Miri Fujita,Masahiro Maeda

Clinical Case Reports（2021）

引用 4|浏览12

暂无评分

摘要

Key Clinical MessageThe tumor reduction effect of pembrolizumab is extremely high compared to standard chemotherapy and might show prolonged survival. Therefore, the MSI status should be examined in patients with cholangiocarcinoma.

查看译文

关键词

cholangiocarcinoma, microsatellite instability-high, pembrolizumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要